(Secondary prevention of coronary heart disease and peripheral artery disease combining antiaggregation and anticoagulation therapy. Expert consensus statement of the Czech Society of Cardiology, the Czech Society of Internal Medicine and the Czech Society of Angiology to the outcomes of COMPASS trial)

Autor:	Richard Ceska, Hana Rosolová, Petr Widimský, Miloš Táborský, Lubanda Jc, Aleš Linhart, Debora Karetová
Rok vydání:	2019
Předmět:	business.industry Medicine Cardiology and Cardiovascular Medicine business
Zdroj:	Cor et Vasa. 61:e334-e340
ISSN:	1803-7712 0010-8650
DOI:	10.33678/cor.2019.019
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d466e91b740430c893f93c3622c9efbe https://doi.org/10.33678/cor.2019.019 Zobrazit plný text záznamu